Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Advances in Experimental Medicine and Biology
|
August 24, 2007
Gangliosides as immunomodulators
Miroslava Potapenko, Galina V Shurin, Joel de León
Vaccine
|
December 1, 2005
Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens
Circe Mesa, Joel de León, Luis E Fernández
Revista Peruana De Medicina Experimental Y Salud Publica
|
June 11, 2020
[Cancer immunotherapy: from inception to Nobel Prize]
Liliana Vasquez, Denisse Castro, Joel de León, et al.
Vaccine
|
August 7, 2004
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation
Circe Mesa, Joel De León, Kevin Rigley, et al.
Vaccine
|
July 11, 2006
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for dendritic cell activation
Circe Mesa, Joel de León, Kevin Rigley, et al.
Cellular Immunology
|
May 21, 2014
Oncogenic transformation tunes the cross-talk between mesenchymal stem cells and T lymphocytes
Nilda Sánchez, Alex Miranda, Juan M Funes, et al.
Revista Peruana De Medicina Experimental Y Salud Publica
|
February 11, 2026
T-cell exhaustion and antibody response in SARS-CoV-2 vaccine recipients
Iván Lozada-Requena, Camila A Arones-Santayana, Angela Vidal Riva, et al.
International Immunology
|
March 4, 2008
Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function
Joel de León, Audry Fernández, Marilyn Clavell, et al.
Cancer Research
|
June 13, 2015
Oncogenic Transformation Can Orchestrate Immune Evasion and Inflammation in Human Mesenchymal Stem Cells Independently of Extrinsic Immune-Selective Pressure
Alex Miranda, Juan M Funes, Nilda Sánchez, et al.
Molecular Cancer Therapeutics
|
July 23, 2008
Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity
Lourdes Roque-Navarro, Krittalak Chakrabandhu, Joel de León, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Advances in Experimental Medicine and Biology
|
August 24, 2007
Gangliosides as immunomodulators
Miroslava Potapenko, Galina V Shurin, Joel de León
Vaccine
|
December 1, 2005
Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens
Circe Mesa, Joel de León, Luis E Fernández
Revista Peruana De Medicina Experimental Y Salud Publica
|
June 11, 2020
[Cancer immunotherapy: from inception to Nobel Prize]
Liliana Vasquez, Denisse Castro, Joel de León, et al.
Vaccine
|
August 7, 2004
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation
Circe Mesa, Joel De León, Kevin Rigley, et al.
Vaccine
|
July 11, 2006
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for dendritic cell activation
Circe Mesa, Joel de León, Kevin Rigley, et al.
Cellular Immunology
|
May 21, 2014
Oncogenic transformation tunes the cross-talk between mesenchymal stem cells and T lymphocytes
Nilda Sánchez, Alex Miranda, Juan M Funes, et al.
Revista Peruana De Medicina Experimental Y Salud Publica
|
February 11, 2026
T-cell exhaustion and antibody response in SARS-CoV-2 vaccine recipients
Iván Lozada-Requena, Camila A Arones-Santayana, Angela Vidal Riva, et al.
International Immunology
|
March 4, 2008
Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function
Joel de León, Audry Fernández, Marilyn Clavell, et al.
Cancer Research
|
June 13, 2015
Oncogenic Transformation Can Orchestrate Immune Evasion and Inflammation in Human Mesenchymal Stem Cells Independently of Extrinsic Immune-Selective Pressure
Alex Miranda, Juan M Funes, Nilda Sánchez, et al.
Molecular Cancer Therapeutics
|
July 23, 2008
Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity
Lourdes Roque-Navarro, Krittalak Chakrabandhu, Joel de León, et al.
Page
of 2